According to IMARC Group’s latest report, titled “E. Coli Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the global E. Coli testing market reached a value of US$ 1.70 Billion in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 7.4% during 2021-2026.
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviors of the consumers globally–our estimates about the latest market trends and forecast values after considering the impact of this pandemic. These observations will be integrated into the report.
Request for a free sample copy of this report: https://www.imarcgroup.com/e-coli-testing-market/requestsample
Escherichia coli (E. Coli) testing refers to clinical tests conducted to detect the presence of food-borne E. Coli bacteria. These pathogens are commonly found in the environment, intestines of warm-blooded animals, and foods, such as meat, dairy, and raw fruits. Some strains of e. coli are identified to cause several medical complications, including gastrointestinal tract infections, bacteremia, neonatal meningitis, cholangitis, urinary tract infection (UTI), and pneumonia. The common e. coli testing methods include membrane filtration, multiple tube fermentation (MTF), enzyme-substrate, presence/absence (P/A) tests, stool culture, and pulsed-field gel electrophoresis (PFGE).
Market Trends and Drivers:
The global e. coli testing market is majorly being driven by the increasing prevalence of water-borne diseases, such as diarrhea and hemolytic uremic syndrome (HUS). This, in turn, is catalyzing e. coli testing in wastewater treatment plants to measure the effectiveness of effluent disinfection in water. Additionally, the increasing instances of e. coli infections, along with the rising emphasis on hygiene are further facilitating the demand for quick and precise test kits across the globe. Besides this, rapid technological advancements, such as the development of innovative bacterial diagnostic instruments and polymerase chain reaction (PCR) tests for environmental testing, are creating a positive outlook for the market.
- Coli Testing Market 2021-2026 Competitive Analysis and Segmentation:
Competitive Landscape With Key Players:
The competitive landscape of the E. Coli testing market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
- Accugen Laboratories Inc.
- Alere Inc. (Abbott Laboratories)
- BD (Becton Dickinson and Company)
- bioMérieux (INSTITUT MERIEUX)
- Bio-RAD Laboratories Inc.
- Enzo Life Sciences Inc. (Enzo Biochem Inc.)
- Idexx Laboratories Inc.
- Johnson & Johnson
- Meridian Bioscience Inc.
- Nanologix Inc.
- Pro-Lab Diagnostics
- Qiagen N.V.
- Thermo Fisher Scientific Inc
Key Market Segmentation:
The report has segmented the global E. Coli testing market on the basis of product, test type, end user and region.
Breakup by Product:
- Consumables
- Instruments
Breakup by Test Type:
- Environmental Test
- Membrane Filtration (MF)
- Multiple Tube Fermentation (MTF)
- Enzyme Substrate Methods
- Clinical Test
- Polymerase Chain Reaction (PCR) Tests
- Enzyme Immunoassays (EIA)
- Others
Breakup by End User:
- Hospitals and Clinics
- Diagnostic Laboratories
- Others
Breakup by Region:
- North America
- Asia Pacific
- Europe
- Latin America
- Middle East and Africa
Explore Full Report with TOC & List of Figure: https://bit.ly/3mDPe4e
Key Highlights of the Report:
- Market Performance (2015-2020)
- Market Outlook (2021-2026)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- The Impact of COVID-19 on the Global Market
- Value Chain Analysis
- Structure of the Global Market
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, and nanotechnology industries. We also provide cost model and manufacturing setup project reports through Syndicated Analytics, a subsidiary of IMARC Group.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact US:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Website: https://www.imarcgroup.com/
Email: [email protected]
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800
According to IMARC Group’s latest report, titled “Wearable patch Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026,” the global wearable patch market witnessed strong growth during 2015-2020.
Looking forward, IMARC Group expects the market to grow at a CAGR of around 15% during 2021-2026.As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviors of the consumers globally–our estimates about the latest market trends and forecast values after considering the impact of this pandemic.
These observations will be integrated into the report.Request for a free sample copy of this report: https://www.imarcgroup.com/wearable-patch-market/requestsampleWearable patches, also known as electronic skin and smart patches, are used for drug delivery, disease monitoring, and diagnosis.
They can be worn or stuck to the skin directly on the affected body part to collect data at regular intervals and transmit information to health information systems (HIS) or even smartphones.
Wearable patches can monitor oxygen levels, blood pressure, heart rate, glucose level, and body temperature.
Market players have introduced product variants with advanced features enabling continuous monitoring of patients, coupled with precise data, minimal interference with body movements, and more effortless connectivity with smartphones.
Market’s ViewpointThe Global Biomarkers Market 2020 shares are rising as the COVID 19 pandemic destabilizes other markets that struggle with the closure of businesses globally.
This compulsion during a time of isolation, job loss, and stress is witnessed to be more, according to data collected by Market Research Future experts.
Yet, the Biomarkers Market is expected to garner revenue of USD 4,582.8 Million by 2027, while soaring at 10.28% through the years 2020 to 2027—the forecast period.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/1941Biomarkers Market—Boomers & DeclinersThe biomarkers market worldwide is on the growth path, thanks to the ever-increasing use of biomarkers in the field of medicine.
Biomarkers also offer tremendous support for efficient clinical decision making, which is mainly dependent on diagnosing the health status of a patient.
Due to these factors, the market for biomarkers is expanding rapidly for decades.Further, with the growing popularity of biomarkers, an escalating number of pharmaceutical companies are using biomarkers in its drug development efforts.
The global economic downturn was futile to have a detrimental effect on the biomarkers market worldwide when COVID 19 fell into action.
The latest trending report Global Life Science Tools & Reagents Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 offered by DecisionDatabases.com is an informative study covering the market with detailed analysis.
The report will assist reader with better understanding and decision making.The global Life Science Tools & Reagents market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.6% in the forecast period of 2020 to 2025 and will expected to reach USD 59 million by 2025, from USD 51 million in 2019.The Life Science Tools & Reagents market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.Final Report will cover the impact of COVID-19 on this industry.Browse the complete report and table of contents @ https://www.decisiondatabases.com/ip/29177-life-science-tools-and-reagents-market-analysis-reportThe major players covered in Life Science Tools & Reagents are:Abbott LaboratoriesCell Signaling TechnologyBeckman Coulter Inc.AbcamCell SciencesBD BiosciencesCharles River Laboratories International Inc.Bio-Rad LaboratoriesBenitecCepheid Inc.Illumina Inc.Luminex Corp.Echelon Biosciences Inc.Sysmex-Partec GmbhLifesensors Inc.High Throughput Genomics Inc.Emd MilliporeStemgentLonza Group AGEnzo BiochemThermo Fisher Scientific Inc.Xenotech LlcWaters Corp.Vitro Diagnostics Inc.Trilink BiotechnologiesTocris Bioscience (Bio-Techne)By Type, Life Science Tools & Reagents market has been segmented intoToolsReagentsBy Application, Life Science Tools & Reagents has been segmented into:ProteomicsCell biology researchEpigeneticsMetabolomicsBioinformaticsOthersThe report offers in-depth assessment of the growth and other aspects of the Life Science Tools & Reagents market in important countries (regions), including:North America (United States, Canada and Mexico)Europe (Germany, France, UK, Russia and Italy)Asia-Pacific (China, Japan, Korea, India and Southeast Asia)South America (Brazil, Argentina, etc.
)Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)Download Free Sample Report of Global Life Science Tools & Reagents Market @ https://www.decisiondatabases.com/contact/download-sample-29177The content of the study subjects, includes a total of 15 chapters:Chapter 1, to describe Life Science Tools & Reagents product scope, market overview, market opportunities, market driving force and market risks.Chapter 2, to profile the top manufacturers of Life Science Tools & Reagents, with price, sales, revenue and global market share of Life Science Tools & Reagents in 2018 and 2019.Chapter 3, the Life Science Tools & Reagents competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.Chapter 4, the Life Science Tools & Reagents breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.Chapter 12, Life Science Tools & Reagents market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.Chapter 13, 14 and 15, to describe Life Science Tools & Reagents sales channel, distributors, customers, research findings and conclusion, appendix and data source.Purchase the complete Global Life Science Tools & Reagents Market Research Report @ https://www.decisiondatabases.com/contact/buy-now-29177All Reagent Related Reports by DecisionDatabases.com @ https://goo.gl/JgqsoUAbout-Us:DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics.
DecisionDatabases.com is proficient in providing syndicated research report, customized research reports, company profiles and industry databases across multiple domains.Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors.
We provide intellectual, precise and meaningful data at a lightning speed.For more details:DecisionDatabases.comE-Mail: [email protected]: +91 9028057900Web: https://www.decisiondatabases.com/News Source - https://www.industrynewsengine.com/2020/10/21/life-science-tools-reagents-market-report-till-2025-global-manufacturers-analysis/
Global Biomarkers Market: Information By Product (Consumables, Services, Software), By Type (Safety Biomarkers, Validation Biomarkers, Efficacy Biomarkers), By Application (Diagnostics, Personalized Medicine, Drug Discovery and Development, Disease Risk Assessment) and By Disease Indication (Cancer, Neurological Disorders, Cardiovascular Disorders, Immunological Disorders, Others) - Forecast till 2027Market OverviewMarket Research Future (MRFR) studied the worldwide biomarkers market 2020 across the analysis period (between 2017 and 2027).
The gradual surge in cases of chronic and life-threatening ailments is creating intense need for detailed diagnostic procedures.
The upscaling demand for biomarkers as a potential diagnostic solution and rise in number of suppliers, producers, and distributors of biomarkers are observe to generate considerable revenue.
The adoption of technological developments in multiplex biomarkers platform and sequence profiling tools can contribute to the expansion of the market in the near future.
The increase in incidences of lasting diseases is creating the need for clinical trials, precise therapy, and diagnosis push.
The increasing cases of neurological disorders is creating the need for biomarkers MRFR study suggests that the biomarkers segment is expected to surge at 10.69% CAGR in the study period.Regional AnalysisIn North America, the biomarkers market is likely to rise at high pace in the years to come.
According to the latest report by IMARC Group, titled “Premium Denim Jeans Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026,” the global premium denim jeans market size exhibited moderate growth during 2015-2020.
Looking forward, IMARC Group expects the global premium denim jeans market to grow at a CAGR of around 5% during 2021-2026.
A pair of jeans represent one of the most commonly worn items in an individuals’ closet.
It is classified into different types based on numerous factors, amongst which price acts as a major factor for differentiating premium denim jeans from its affordable counterparts.
Premium denim jeans enhance the overall aesthetic appeal of an individual, owing to which its sales are boosting across the globe.As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviors of the consumers globally-our estimates about the latest market trends and forecast values after considering the impact of this pandemic.
These observations will be integrated into the report.Request for a free sample copy of this report: https://www.imarcgroup.com/premium-denim-jeans-market/requestsampleMarket Trends:Rapid urbanization, in confluence with inflating disposable income, represents one of the significant factors bolstering the global premium denim jeans market growth.
According to IMARC Group’s latest report, titled “Point-of-Care Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the global point-of-care diagnostics market reached a strong growth in 2020.
Point-of-care (PoC) diagnostics include the medical testing conducted to obtain a quick diagnosis and instant detection of critical illnesses.
It also aids in delivering diagnostic facilities to remote locations where setting up a clinical laboratory is challenging.
The testing equipment is often integrated with medical vehicles, including helicopters, air ambulances, airplanes, and spacecraft.Request for a PDF sample of this report: https://www.imarcgroup.com/point-of-care-diagnostics-market/requestsampleThe high prevalence of chronic diseases, along with the rising geriatric population, is augmenting the demand for point-of-care (PoC) diagnostics.
These records facilitate the direct transmission of test results from PoC devices to the lab specialists, thus reducing the chances of discrepancies.
Besides this, rising R activities to develop molecular diagnostic devices and the growing demand for early disease detection are anticipated to boost the point-of-care (PoC) diagnostics market.
